Ikena’s pipeline is supported by scientific research published by the Ikena R&D team, our collaborators, and by external experts.


Our pipeline is supported by scientific research performed by our in-house team and by external experts.

For links to relevant scientific publications and abstracts, please see below (subscriptions may be required to access full text of certain publications):

Sep 2019 | From External Experts

Metabolomic adaptations and correlates of survival to immune checkpoint blockade

Apr 2019 | From External Experts

Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

Mar 2019 | From External Experts

Impact of ERK5 on the Hallmarks of Cancer

Feb 2019 | From External Experts

MEK5 promotes lung adenocarcinoma

Sep 2018 | From Ikena Oncology

Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

Developing breakthrough, patient-directed therapies for difficult to treat cancers.